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Alejandro Santos-Mayo1, Rosa de Hoz2,3, Raquel Yubero4, pedro Gil4 & José M. Ramírez  2
the retina is an attractive source of biomarkers since it shares many features with the brain. thickness 
differences in 10 retinal layers between 19 patients with mild Alzheimer’s disease (AD) and a control 
group of 24 volunteers were investigated. Retinal layers were automatically segmented and their 
thickness at each scanned point was measured, corrected for tilt and spatially normalized. When the 
mean thickness of entire layers was compared between patients and controls, only the outer segment 
layer of patients showed statistically significant thinning. However, when the layers were compared 
point-by point, patients showed statistically significant thinning in irregular regions of total retina and 
nerve fiber, ganglion cell, inner plexiform, inner nuclear and outer segment layers. Our method, based 
on random field theory, provides a precise delimitation of regions where total retina and each of its 
layers show a statistically significant thinning in AD patients. All layers, except inner nuclear and outer 
segments, showed thickened regions. new analytic methods have shown that thinned regions are 
interspersed with thickened ones in all layers, except inner nuclear and outer segments. Across different 
layers we found a statistically significant trend of the thinned regions to overlap and of the thickened 
ones to avoid overlapping.
Alzheimer’s disease (AD) is an increasing health issue for elderly people and healthcare services in developed 
countries. There is wide agreement about the relevance of its early detection, leading to interest in early, conven-
ient and affordable biomarkers. The brain is the main tissue affected in AD, and the retina is the only neuronal 
tissue that can be analyzed non-invasively in AD. Increasing evidence suggests that retinal analysis can provide 
insights into brain pathology. In a sample of 2,124 patients with mild AD, Mutlu et al. found that a thinner gan-
glion cell layer (GCL), nerve fiber layer (NFL) and inner plexiform layer (IPL) are associated with smaller grey 
matter, white matter and hippocampal volume1. Ong et al. found that thinner total retinal thickness is associated 
with smaller grey matter volume only in the temporal lobe, whereas thinner GC-IPL complex is associated with 
smaller grey matter and white matter volumes in the temporal lobe, as well as smaller grey matter volume in the 
occipital lobe2. Casaletto et al. found thinner retinal thickness and GCL to be related to medial temporal lobe 
atrophy3. In a homogeneous sample of patients with early-stage AD, Salobrar-Garcia et al.4 found that peripap-
illary total retinal thinning accompanies AD development. More recently, our group has found that retinal thin-
ning in the macular area appears at a very early stage of AD5, together with a 40% decrease in contrast sensitivity6. 
All these findings converge to demonstrate that the volume of brain structures involved in AD is related to retinal 
thickness and visual function. This suggests that AD-associated neuronal damage and deposits may occur in the 
retina before they occur in the brain, implying that retinal analyses could allow AD detection during the asymp-
tomatic preclinical period7,8.
Ten retinal layers were segmented and studied: nerve fiber layer (NFL), ganglion cell layer (GCL), inner 
plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), inner 
1Instituto de Tecnología del Conocimiento, Universidad Complutense de Madrid, Madrid, Spain. 2Instituto de 
Investigaciones Oftalmológicas Ramón Castroviejo, Facultad de Medicina, Universidad Complutense de Madrid, 
Madrid, Spain. 3Facultad de Óptica y Optometría, Universidad Complutense de Madrid, Madrid, Spain. 4Unidad 
de Memoria, Servicio de Geriatría, Hospital Clínico San Carlos, Madrid, Spain. Correspondence and requests for 
materials should be addressed to L.J.-E. (email: escalada@ucm.es) or J.M.R. (email: ramirezs@med.ucm.es)
Received: 4 March 2019
Accepted: 24 August 2019
Published: xx xx xxxx
open
2Scientific RepoRtS |         (2019) 9:13000  | https://doi.org/10.1038/s41598-019-49353-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
segments/outer segments layer (IS/OS), outer segment layer (OSL), outer segment PR/RPE complex (OPR) and 
retinal pigment epithelium layer (RPE).
The objective of the present work was three-fold: (1) investigate how much the early development of AD 
affects each retinal layer and compare impact of the disease on different layers; (2) find out how these impacts are 
spatially distributed in each layer; and (3) carry out these tasks using an improved method specifically adapted for 
optical coherence tomography (OCT) studies of retinal thickness.
Results
Demographic and clinical data. Data for patients with mild AD and age-matched controls are shown in 
Table 1. The two groups did not show statistically significant differences in age, gender composition, educational 
level or refractive error. In fact, the distributions of refractive error of both groups were similar and the difference 
was not statistically significant (Kolmogorov-Smirnov Z = 0.7632; p = 0.603). Educational level was categorized 
in terms of years of education as 1, <9 years; 2, 9–17 years; or 3, >17 years. All patients scored >17 on the MMSE 
(Mini-Mental State Examination), and the two groups showed a statistically significant difference in mean score.
Mean thickness of retinal layers in Alzheimer and control groups. Across the entire retinal region 
scanned, the retina was 5.1 µm thinner in patients (n = 19, mean = 281.4 µm, SD = 11.9) than in controls (n = 24, 
mean = 286.5 µm, SD = 16.9). This difference was not statistically significant (Student’s t = −1.08, df = 41, 
p = 0.14). Most retinal layers were slightly thinner in patients (Fig. 1), though the difference was statistically 
significant only in the outer segment layer (OSL) (Student’s t = −2.23, df = 41, p = 0.02). Conversely, the retinal 
pigment epithelium (RPE) was thicker in patients, but this difference was not statistically significant.
Spatial distribution of thickness in each layer. Maps were generated showing mean thickness for a 
central square measuring 4.8 × 4.8 mm2 in each retinal layer (Fig. 2). Thickness appears color-coded in Fig. 2a 
(patients) and 2b (controls). The search for regions with statistically significant thinning was restricted to a circle 
AD Control Difference
p-value(n = 19) (n = 24)
Age* 79.16 ± 3.93 75.71 ± 2.83 0.587††
Gender 0.904†
   Men 6 8
   Women 13 16
Race Caucasian Caucasian
MMSE*
23.42 ± 3.11 28.38 ± 2.02 <0.001††
Range = [17, 29] Range = [25, 31]
Educational level** 1 ± 1 1 ± 0 0.564††
Refractive error*
0.39 ± 1.40 −0.12 ± 1.13 0.184†††
Range = [−2.00, 4.00] Range = [−2.75, 2.25]
Table 1. Demographic and clinical data of patients and controls. *Mean value ± SD; **median ± interquartile 
range; †Proportions z-test; ††Mann–Whitney U-test; †††Student’s t-test [AD, Alzheimer’s disease; MMSE, Mini-
Mental State Examination; SD, standard deviation].
Figure 1. Thickness of each retinal layer in patients (gray bars) and controls (white bars). Mean thickness is 
shown within the bars and standard deviation (SD) above.
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Figure 2. Spatial pattern of AD-related retinal thinning and thickening. Top row shows data of total retina, 
and subsequent rows show data for its 10 layers. Column (a) corresponds to the AD group and shows at 
each scanned point its color-coded thickness mean, as entered in the RFT-based statistical analysis, after 
preprocessing (i. e. after thickness correction, spatial normalization and Gaussian smoothing for signal to noise 
ratio enhancement; see Methods section for details). Column (b) shows the corresponding information for the 
control group. Column (c) displays the statistical parametric map (SPM) for thickness difference (AD-Control), 
thus giving for each scanned point the z-score corresponding to the difference in mean thickness between the 
two groups. Column (d) shows in red color the regions whose thinning in the AD group reached statistical 
significance; thus each red region is formed by the set of scanned points where the z-score of the difference 
(AD-Control) exceeded the critical value Zc; a Zc value was obtained for each retinal layer from RFT analysis 
with the probability of family-wise type I error = 0.05, and is indicated at the bottom of the corresponding figure 
in the rightmost column.
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of diameter 3.5 mm centered on the fovea and drawn in black in Fig. 2. A random field theory (RFT)-based 
search for regions thinner in patients than in controls led to the statistical parametric map9 (SPM) in Fig. 2c, 
where green color means no difference; blue, thinner in patients; and yellow-red, thicker in patients. Figure 2d 
shows in red color on a reference anatomical image the regions of total retina and its layers where thinning in AD 
group reached statistical significance, based on a one-sided test with probability of family-wise type I error set 
at 0.05. The normality and homoscedasticity checks required by RFT techniques revealed statistically significant 
deviations from these assumptions in wide regions of the OPL, IS/OS, OSL and OPR layers, but these deviations 
did not alter our results, since similar results were obtained using a non-parametric random permutation test. 
The results showed a statistically significant thinning of the total retina of patients throughout its central region, 
including the fovea and parafovea, as well as thinning spread out in the upper nasal direction. Regions with sta-
tistically significant thinning were also found in the NFL, GCL, IPL, INL and OSL, at the locations shown in the 
corresponding rows of Fig. 2d. Thinning in the NFL was extrafoveal and in the upper side; as one moved toward 
outer layers, the thinning remained extrafoveal and appeared to rotate counterclockwise. Systematic but not sta-
tistically significant thinning was observed in regions of all other layers except RPE.
Next we analyzed the spatial distribution of AD-related changes in thickness in greater detail; differences in 
thickness between groups are shown in Fig. 3a. In patients, all layers were thinner to different extents and with 
different spatial distributions, with the exception of the RPE, which showed mainly thickening. For each retinal 
layer Fig. 2d offers a precise delimitation of the regions with a statistically significant thinning in the patient 
group: (1) NFL showed statistically significant thinning in the upper part of the parafovea; (2) GCL was thinner 
in a c-shaped area around the temporal side of the foveola, and this thinning reached statistical significance at the 
temporal side close to the foveola center; (3) IPL showed statistically significant thinning in the lower temporal 
quadrant of the parafovea and fovea, even within the foveola but not within the foveal pit; (4) INL was thinner all 
around the foveola, and this thinning was statistically significant in both lateral regions of the parafovea and in 
the lower region of both fovea and parafovea; (5) OPL showed only slight, not statistically significant thinning in 
the lower nasal quadrant of fovea and parafovea; (6) ONL showed thinning, which was not statistically significant, 
over the upper temporal half, including the entire foveal avascular zone; (7) IS/OS showed slight thinning at the 
fovea, without reaching statistical significance; (8) OSL showed a statistically significant decrease of perifoveal 
thickness in a comma form in the superior nasal area; (9) OPR showed only slight, not statistically significant 
thinning in the temporal fovea and parafovea; and (10) RPE also showed slight, not statistically significant thin-
ning in the nasal area.
Some thickened regions were also clearly observed in the ONL and RPE, though the thickening did not 
achieve statistical significance. This thickening may be related to inflammatory processes and may have concealed 
thinning in previous studies where thickness was averaged among regions of different sizes and geometrical 
shapes. In NFL, a small blob of thickening covered the half-nasal part of the foveal avascular zone, outside the 
foveal pit. GCL showed some areas of thickening in the upper areas analyzed, as well as a small blob in the inferior 
macular area. ONL was thicker in the lower nasal para- and perifovea regions. RPE showed a wide thickened 
region dominating the temporal half of the scanned area. Thickening found in the NFL, GCL and RPE did not 
reach statistical significance.
Area of thinned and thickened regions in retinal layers. Differences in mean thickness between 
patients and controls were studied at each scanned point within a 4.8 × 4.8-mm2 central square extracted from 
the 6 × 6-mm2 scanned area. Differences in thickness between the two groups are shown in Fig. 3a. The corre-
sponding histogram in Fig. 3b shows the bias of the difference in the negative direction. This confirms the system-
atic dominance of thinned areas in all layers except RPE. Figure 3c shows regions that were classified as thinned 
(black) or thickened (white) in patients, based on thickness differences of any size between AD and control 
group. Figure 3d uses the same color scheme to show regions classified as thinned or thickened in patients when 
a thickness difference greater than 1 SD was required; regions with smaller differences are shown in gray. After 
identifying thinned and thickened regions for each layer of AD patients, we calculated two indices based on their 
corresponding areas. The first index, t0, was the percentage of thinned area when all differences were considered 
(regardless of their magnitude); the second t1, the percentage of area whose thinning exceeded 1 SD. Analogously, 
the percentages of thickened area under the same two conditions, T0 and T1, were also calculated. Numeric values 
obtained for each index at each retinal layer are displayed under the corresponding images in Fig. 3c,d.
Graphical analysis of these indices (Fig. 4) shows that all layers were thinner in patients over an appreciable 
percent of their surface. In addition, all layers except INL and OSL contained areas that were thicker in patients. 
In neural layers, thinned area systematically predominated over thickened area: for all 9 neural layers, mean ± SD 
was 52.24 ± 30.98 for the difference t0-T0 (Student’s t = 5.06, df = 8, p < 0.001) and 38.91 ± 24.14 for the difference 
t1-T1 (Student’s t = 4.84, df = 8, p < 0.001). In RPE the thickened area was twice as large as the thinned area.
Volume of thinned and thickened regions in retinal layers. To investigate AD-related retinal volume 
changes in all retinal layers, we defined, for each layer, vo as the ratio of the volume lost in thinned regions to the 
layer’s mean volume in the AD group, and V0 as the ratio of volume gained in thickened regions to the layer’s 
mean volume in the AD group; these two ratios, vo and V0, took into account any thinning and thickening, regard-
less of its magnitude. We also defined the corresponding ratios v1 and V1 for the case in which only a thickening 
or thinning greater than 1 SD was considered. The results obtained for all layers (Fig. 5) paralleled those found for 
area changes. In neural layers, the ratio of volume lost in thinned regions was systematically greater than the ratio 
of volume gained in thickened regions: for all 9 neural layers, mean ± SD was 0.0528 ± 0.0546 for the difference 
v0-V0 (Wilcoxon T = 0, p < 0.005) and 0.0476 ± 0.0531 for the difference v1-V1 (Wilcoxon T = 0, p < 0.005). In 
RPE, the volume gained in the thickened regions exceeded that lost in the thinned ones.
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Spatial correspondence between thinned and thickened regions of different retinal layers. 
After observing the spatial location of thinned and thickened regions in each of the retinal layers (Fig. 3c,d), we 
examined whether these regions overlap across the layers. A Jaccard similarity index was computed for each pair 
of retinal layers when differences of any size were considered and when only differences >1 SD were considered 
(Table 2). To assess the extent of overlap of thinned regions in any pair of layers Lp and Lq, the Jaccard index Jpq 
was computed using the formula Jpq = C/(A + B − C), where A is the number of thinned points present in Lp, B 
Figure 3. AD-related thinning and thickening of retinal layers. The top row shows data for the total retina; 
subsequent rows show data for each of its layers. (a) The first column shows the color-coded thickness difference 
between patients and controls for each scanned retinal point. (b) The second column displays the histogram 
and the cumulative distribution function for all those differences, together with its mean and SD. (c) The third 
column shows the regions where layers are thinner (black) or thicker (white) in patients, irrespective of the 
size of the difference. (d) The right-most column shows thinner (black) and thicker (white) regions where the 
difference >1 SD; regions with a smaller difference appear in gray. The two values collected under each image of 
the two right-most columns refer to the percentages of thinned (t) and thickened (T) areas in the image above.
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is the number of thinned points present in Lq, and C is the number of thinned points spatially coincident in both 
layers (i. e. the number of points where both layers appear thinned at the same spatial coordinates)10. Overlap of 
thickened regions was analyzed in an analogous manner.
The Jaccard index may be understood as the ratio of real to potential spatial coincidence of thinned (or thick-
ened) regions in the two retinal layers being compared. A Jaccard value of 1 means maximum coincidence and 0, 
maximum incompatibility. Most values in Table 2 are statistically significant, leading to the conclusion that the 
location of thinned regions in any retinal layer correlated with the location of thinned regions in other layers, and 
that the locations of thickened regions also correlated across layers. But the sense of the correlation is different for 
thinned and thickened regions: most values below the main diagonal of the upper matrix in Table 2 are greater 
than randomly expected, while most values above the diagonal are lower than randomly expected. In other words, 
thinned regions co-located with one another to a statistically significant extent across layers, while thickened 
regions “avoided” co-localization to a statistically significant extent across layers (cf. OPL and ONL in Fig. 3c,d).
Discussion
Thickness changes in the 10 retinal layers were studied in patients with AD at a very early stage of disease devel-
opment. We automatically segmented 10 retinal layers, evaluated their thickness at each retinal point scanned, 
and searched for spatial patterns of thickness differences between patients and controls. All 10 layers showed 
AD-related thinning over a relevant percent of their surface, and thinning reached statistical significance at var-
ious locations in NFL, GCL, IPL, INL, OSL and total retina. All layers except INL and OS also showed thickened 
regions, though their thickening did not reach statistical significance. In neural layers thinned regions showed 
a statistically significant increase in area over that of thickened ones, whereas the opposite was observed in the 
RPE. Volume lost in thinned regions of neural layers was greater than volume gained in thickened regions, the 
difference being statistically significant; the opposite was again observed in the RPE. Across different retinal lay-
ers, thinned regions appeared to co-localize while thickened regions appeared to “avoid” co-localization, in both 
cases to a statistically significant extent.
Some layers affected by AD in our study differ from those found in some previous studies. Most studies 
reported a statistically significant thinning in inner layers11–14, but these results were obtained by analyzing all 
layers separately without any aggregation (e.g. GC-IPL) and by calculating only mean measures of an area. Our 
results are in agreement with those of Garcia-Martin et al.13. Their study and ours detected AD-related thinning 
of the NFL and ONL, but our method allowed us to go further by building a color-coded quantitative map of 
Figure 4. Percentage of thinned and thickened areas in retinal layers. Red lines show results for regions thicker 
(empty circles) or thinner (filled circles) in patients by any magnitude; blue lines, for regions thicker (empty 
circles) or thinner (filled circles) in patients by 1 SD or more.
Figure 5. Ratio of volume lost in thinned regions and gained in thickened regions of each macular layer. Red 
lines show results for regions thicker (empty circles) or thinner (filled circles) in patients by any magnitude; blue 
lines, for regions thicker (empty circles) or thinner (filled circles) in patients by 1 SD or more.
7Scientific RepoRtS |         (2019) 9:13000  | https://doi.org/10.1038/s41598-019-49353-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
thinned areas, which helped us delimit the location of macular thinning in mild AD with greater accuracy than 
in previous studies. Studies of AD patients with MMSE scores of 17.02 to 19.9 have suggested that inner retinal 
thinning parallels the decrease in MMSE score, reflecting disease progression11–16. Interestingly, we were able to 
detect macular thinning even at a quite early stage of AD in patients with an MMSE score of 23.42.
The thinning found in retinal layers may correspond to loss of ganglion, amacrine and bipolar cells, which 
may translate to visual function damage in early stages of AD. Loss of these cells means a loss in spatial sampling 
frequency of receptive fields tuned to all spatial frequencies, which may seriously disturb convolutional computa-
tion of all mono- and multi-channel processing. Indeed, this neuronal loss may help explain the observed nearly 
40% loss of psychophysical contrast sensitivity in AD patients6. A possible explanation for the superior retinal 
thinning observed in our patients is that amyloid-β (Aβ) deposits and tau tangles predominate in the superior 
region of AD retinas17–24. Indeed, senile plaques and neurofibrillary tangles in AD are densest in the cuneal gyrus 
of the primary visual cortex, whose axons project from the superior retina17,23,25–28.
An observation that caught our attention was that in our patients with mild AD, various retinal layers were 
thicker than the corresponding regions in controls. Our previous work in patients with early AD revealed thick-
ening of the total retina, which we attributed to an early phase of neural inflammation prior to the degenerative 
process4. Another possible explanation for retinal thickening in mild AD is gliosis. Like García-Martín et al.13, 
we detected thickening in the INL, and also in GCL, IPL, OPL and ONL, although this never reached statistical 
significance in our study. The thickening in the GCL and IPL was distributed such that thicker voxels surrounded 
foveal voxels that were affected by statistically significant thinning, which highlights the ability of our method to 
gain detailed insights into the nature of retinal changes in AD.
Previous studies reported a statistically significant thinning of total retinal thickness in AD11–13, but those stud-
ies were limited because they could not identify which retinal layers were most affected. As a result, two of those 
three studies11,12 included the ganglion cell layer. García-Martín et al.13 have also reported on AD-related changes 
in mean thickness of each retinal layer in the macular area. Their patients had more advanced AD than ours, 
which may help explain why their observation of thinning in NFL, GCL, IPL and ONL differs from ours. Indeed, 
retinal thickness is known to correlate directly with MMSE score, with more advanced AD stage associated with 
more thinning12,14,15,29–31. AD progression may also explain why previous studies of retinal layer thickness in 
AD patients reported thinning but not thickening of inner retinal layers11–16, whereas we observed thickening 
in our patients with early AD. Aside from disease differences, some technical factors may also contribute to this 
NFL GCL IPL INL OPL ONL IS/OS OSL OPR RPE
Thickness differences of any size
NFL 1 0.25 ** 0.13 ** 0.09 * 0.22 ** 0.09 ** 0.39 — 0.01 — 0.06 ** 0.38 —
GCL 0.46 *** 1 0.11 ** 0.09 * 0.17 ** 0.18 ** 0.39 — 0.01 — 0.09 * 0.33 *
IPL 0.54 *** 0.42 *** 1 0.04 * 0.12 ** 0.31 * 0.19 ** 0.01 — 0.09 ** 0.21 *
INL 0.67 *** 0.57 *** 0.72 *** 1 0.00 ** 0.10 * 0.08 * 0.02 — 0.02 ** 0.06 *
OPL 0.58 *** 0.46 *** 0.58 *** 0.68 *** 1 0.03 ** 0.21 ** 0.00 — 0.07 ** 0.26 *
ONL 0.46 *** 0.43 *** 0.68 *** 0.70 *** 0.47 *** 1 0.14 ** 0.01 — 0.05 ** 0.30 *
IS/OS 0.58 *** 0.49 *** 0.49 *** 0.56 *** 0.48 *** 0.39 *** 1 0.00 — 0.08 ** 0.38 —
OSL 0.68 *** 0.56 *** 0.76 *** 0.93 *** 0.73 *** 0.71 *** 0.56 *** 1 0.01 — 0.00 —
OPR 0.62 *** 0.53 *** 0.71 *** 0.85 *** 0.68 *** 0.64 *** 0.52 *** 0.90 *** 1 0.04 **
RPE 0.33 — 0.18 ** 0.24 * 0.27 — 0.27 * 0.28 * 0.23 ** 0.27 0.21 * 1
Thickness differences >1 SD
NFL GCL IPL INL OPL ONL IS/OS OSL OPR RPE
NFL 1 0.02 ** 0.00 * 0.00 — 0.11 * 0.00 ** 0.07 ** na 0.01 — 0.16 *
GCL 0.28 ** 1 0.00 * 0.02 — 0.09 * 0.06 ** 0.09 ** na 0.01 — 0.07 **
IPL 0.28 ** 0.23 ** 1 0.00 — 0.03 * 0.06 * 0.01 * na 0.00 — 0.04 *
INL 0.35 * 0.35 — 0.43 *** 1 0.00 — 0.00 — 0.03 — na 0.00 — 0.00 —
OPL 0.17 ** 0.20 ** 0.24 ** 0.22 ** 1 0.00 ** 0.05 ** na 0.00 — 0.08 *
ONL 0.35 * 0.23 ** 0.37 * 0.43 *** 0.12 ** 1 0.01 ** na 0.00 — 0.14 *
IS/OS 0.16 ** 0.30 * 0.22 ** 0.25 * 0.16 ** 0.12 ** 1 na 0.00 — 0.08 *
OSL 0.40 *** 0.29 — 0.42 *** 0.62 *** 0.31 * 0.51 *** 0.23 — 1 na na
OPR 0.24 ** 0.22 ** 0.29 ** 0.35 * 0.22 ** 0.31 ** 0.17 ** 0.40 *** 1 0.00 —
RPE 0.13 * 0.01 ** 0.08 * 0.08 * 0.07 ** 0.09 * 0.04 ** 0.08 * 0.03 ** 1
Table 2. Spatial coincidence of thinned and thickened regions across retinal layers in AD patients. Jaccard 
coefficients for spatial coincidence of thinned regions of each pair of layers are shown below the main diagonals 
of the two correlation matrices; coefficients for thickened regions are shown above. The matrix on the top has 
been obtained when the classification of regions as thinned or thickened was based on thickness differences of 
any size between AD and control groups; and the matrix at the bottom when differences >1 SD were required. 
Results of statistical significance testing are indicated as follows: —, statistically non-significant; *p < 0.05; 
**p < 0.01; ***p < 0.001, where these p values represent the probability of family-wise type I error in two-tailed 
tests for the set of 45 Jaccard values obtained for thinned/thickened regions.
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discrepancy. One factor is the OCT software used: only the latest-generation OCT allows segmentation of the 10 
retinal layers. Another factor is differences in spatial segmentation approaches used to analyze macular thickness. 
The use of wide regions (e.g. concentric rings), instead of the unconstrained search applied in the present work, 
may cause thickening and thinning within the same region to cancel each other out. This means that thickness 
changes may go undetected.
In AD, appearance of Aβ in the brain and retina coincides with activation of surrounding microglia. The 
presence of Aβ in the retina can even precede deposits in the brain27. Microglia respond to Aβ deposition and 
accumulate within and around plaques32,33, where they may engage in phagocytosis. Microglia number and size 
correlate directly with plaque dimensions18,34–36, and microglia in AD patients show statistically significant acti-
vation37,38. The microglial distribution in several retinal layers where we observed thickening leads us to postulate 
that the thickening could reflect microglial activation, at least in some cases. Activation triggers several changes 
in microglia that may thicken the retinal layer, including greater branching, process shortening and thickening, 
migration to the nearest nuclear layer, increase in number and increase in retinal area occupied39–42. In response 
to insults, microglia can take on macrophage-like morphology, becoming “ameboid microglia” lacking cell pro-
cesses43–47. Ameboid microglia are commonly found in the vicinity of lesions in neuroinflammatory disorders48, 
and they have been reported in neurodegenerative diseases such as multiple sclerosis and AD49.
Although they may help to remove Aβ, microglia may actually contribute to degeneration by triggering 
inflammation. The interaction of Aβ and microglia leads to production of chemokines and neurotoxic cytokines 
destructive to the central nervous system50. Activated microglia can degrade the extracellular matrix, promote 
the retraction of dystrophic axons and destabilize synapses51,52. This so-called “synaptic stripping”53,54 has been 
observed in neurodegenerative diseases, such as glaucoma, where retinal ganglion cell synapses are elimi-
nated early in disease progression41,55,56. This can cause transneuronal degeneration, which may account for the 
observed thinning in the GCL, INL and OSL of our patients. Such transneuronal degeneration may help explain 
the observed thinning in the photoreceptor outer segments in our patients. Another possible explanation is pho-
toreceptor degeneration induced by amyloid aggregation, as seen in animal models22,57.
During the last decades, in vivo analysis of the retina from optical cross sections in OCT has improved sub-
stantially due to hardware and software advances. Initially, only total thickness of the retina could be exam-
ined, from the vitreo-retinal interface to the RPE. Then, it became possible to discriminate between internal 
and external retina, and now the higher resolution provided by spectral domain OCT combined with software 
improvements allows separation of up to 11 retinal layers. A key difference between the methods commercially 
available and ours described here is that commercial methods provide the mean thickness of each retinal layer in 
geometrically predetermined areas. Our method, in contrast, explores a 6 × 6 mm2 square at the pixel level with-
out prior constraints, thus avoiding the risk that geometrically predetermined regions may lead to averaging that 
masks clinically relevant differences. Our spatially unconstrained analysis of retinal layers allows us to identify 
which layers are truly affected by the disease. Our analysis also applies spatial standardization and correction for 
distortions coming from OCT techniques and from individual differences, before data are combined for analysis. 
In fact, the present study appears to be the first to correct thickness values for local tilt of retinal layers. Moreover, 
RFT-based statistical analysis allows precise identification of the location, extension and shape of the retinal 
regions in which the two groups differ. Most of these approaches are well established in brain research, but the 
present work appears to be their first systematic application to OCT studies of retinal thickness. The methods 
described here may be also useful for other types of retinal studies and other disease contexts.
Our findings are consistent with histopathological studies of human eyes36 suggesting that changes in retinal 
thickness may be a consequence of neuronal degeneration and inflammatory processes caused by AD-specific 
accumulation of retinal deposits that precede the appearance of deposits in the brain.
The detailed insights in this study were made possible by our novel method involving spatial normalization 
of OCT data and correction of thickness measurements for global, curvature and local tilt in each retinal layer. 
Moreover the present study is the first, to our knowledge, to apply local tilt correction. Our method is supported 
by custom-made software that performs statistical analyses based on Gaussian random field and random permu-
tation theories. These statistical methods have four main advantages over classical ones: (1) they allow searches 
for thickness changes at pixel resolution, giving much finer spatial resolution than previous studies based on 
predefined grids14,58; (2) they provide precise information about the spatial localization, shape and size of thinned 
(and thickened) regions in each layer; (3) they avoid masking and biasing results as a consequence of the shape 
and location of predefined search regions, such as ETDRS or rectangular grids; and (4) they are better suited for 
multiple comparisons than Bonferroni correction because they count on the spatial autocorrelation inherent 
in OCT data. Thus the proposed methods may contribute to solving existing controversies and providing more 
accurate and informative analyses of changes in normal and pathological retinas over time.
Methods
Subjects. In this cross-sectional study, participants were recruited from the database of the Memory Unit of 
the Geriatric Service of the Hospital Clínico San Carlos (Madrid, Spain). The study protocol followed the princi-
ples of the Declaration of Helsinki and was approved by the institutional Ethics Committee for Clinical Research 
of the Hospital Clínico San Carlos (code number 11/372-E). All participants gave written informed consent.
Review of the records of 2,635 patients allowed us to identify 87 with mild AD, defined as GDS 4 according 
to the NINCDS-ADRDA Alzheimer’s Criteria. These patients underwent a full neurological examination and 
magnetic resonance imaging of the brain to rule out alternative diagnoses. Their ophthalmic medical records were 
also reviewed and those who had been previously diagnosed with an ophthalmological disease (glaucoma or sus-
pected glaucoma, media opacity, and retinal diseases) were excluded. This left 29 patients with GDS 4 who were 
free of ocular disease and systemic disorders that might affect their vision. These 29 patients with mild AD and 
37 age-matched healthy control subjects, who scored above 27 on the Mini Mental State Examination (MMSE), 
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underwent a complete ophthalmological examination. Six patients and nine controls were subsequently excluded 
due to posterior pole pathology including macular degeneration, drusen, suspicion of glaucoma, glaucoma, 
epiretinal membrane, or cataracts that prevented ocular examination. Another four patients and four controls 
were excluded because signal intensity was inconsistent across the OCT scan. The remaining 19 patients and 25 
controls were subjected to a complete ophthalmologic examination conducted by the same clinician. This exam-
ination involved assessment of visual acuity, refraction, slit-lamp analysis of the anterior and posterior segments 
of the eye, applanation tonometry (Perkins MKII tonometer, Haag Streit-Reliance Medical, Switzerland), dilated 
fundus examination and OCT. All participants showed an AREDS Clinical Lens Standards <2, a best-corrected 
visual acuity of 20/40, spherocylindrical refraction within ±5 diopters and intraocular pressure below 20 mmHg. 
After enrollment, one subject of the control group was excluded because automatic layer segmentation succeeded 
only for a quite small region. In the end, 19 patients and 24 controls were included in the study.
Only the right eye of each subject was studied; however data from the right eye of 4 patients were of insuf-
ficient quality, so their left eye was studied instead. In these cases, the OCT data were left-right flipped so that 
anatomical areas (temporal-nasal) became equivalent for all subjects. Optical coherence volumes were obtained 
after pupil dilatation using a spectral domain OCT (3D OCT-1000 Topcon, Japan). Three high-quality peri-
papillary and macular images were obtained in a raster pattern covering a 6 × 6-mm area with a scan density of 
512 × 128 pixels in ∼2.5 sec (27000 A scans/sec)59. Voxel size was 11.71875 × 46.875 × 3.5 µm3 (horizontal x ver-
tical x depth), according to the calibration provided by the manufacturer. All OCT images were acquired by the 
same experienced technician, always keeping the light beam entry point centered on the pupil to avoid an oblique 
scanning artifact. Images were reviewed for quality, and the criteria for acceptable fundus images were as follows: 
(A) no large eye movements, defined as an abrupt shift completely disconnecting a large retinal vessel; (B) con-
sistent signal intensity across the scan; and (C) no black bands (caused by blinking) throughout the examination. 
In addition, the criteria for acceptable scanning were (D) a signal-to-noise ratio >30 and acceptance of >95% of 
A-scans during fast nerve fiber layer (NFL) scanning.
Analysis steps. The following steps were applied to data from all subjects. (A) Raw data from macular 
and papillary SD-OCT (or, in some cases, the DICOM version) were exported and processed using the Layer 
Segmentation Module (Iowa Reference Algorithms 3.6 Retinal Image Analysis Lab, Iowa Institute for Biomedical 
Imaging, Iowa City, IA, USA). This software segmented the OCT volume by identifying 11 surfaces, delimiting 10 
retinal layers. (B) The resulting xml files were decoded with an in-house Matlab program to obtain the macular 
and papillary centers, masks for undefined regions where automatic segmentation failed, and 3D coordinates 
of the following 11 delimiting surfaces60–62: (1) inner limiting membrane (ILM), (2) nerve fiber layer-ganglion 
cell layer (NFL-GCL), (3) ganglion cell layer-inner plexiform layer (GCL-IPL), (4) inner plexiform layer-inner 
nuclear layer (IPL-INL), (5) inner nuclear layer-outer plexiform layer (INL-OPL), (6) outer plexiform layer-Henle 
fiber layer (OPL-HFL), (7) boundary of myoid and ellipsoid of inner segments (BMEIS), (8) inner segment-outer 
segment junction (IS/OSJ), (9) inner boundary of OPR (IB_OPR; OPR: outer segment PR/RPE complex), (10) 
inner boundary of retinal pigment epithelium (IB_RPE), and (11) outer boundary of retinal pigment epithelium 
(OB_RPE). All data from A-scans in regions where the segmentation failed were ignored in subsequent analy-
ses. (C) For each A-scan, a raw thickness value T’ was computed for each layer as the difference in µm between 
its two delimiting surfaces, in the direction of the A-scan. In this way, thickness was determined at 128 × 512 
regularly spaced points in the 6 × 6-mm scanned area in the following retinal layers: (1) nerve fiber layer (NFL), 
(2) ganglion cell layer (GCL), (3) inner plexiform layer (IPL), (4) inner nuclear layer (INL), (5) outer plexiform 
layer (OPL), (6) outer nuclear layer (ONL), (7) inner segments/outer segments layer (IS/OS), (8) outer segment 
layer (OSL), (9) outer segment PR/RPE complex (OPR), (10) retinal pigment epithelium layer (RPE), and (11) 
total retina. (D) Raw thickness values T’ were corrected (see below) to estimate true thickness values T for all 
scanned points of each retinal layer. (E) The scanned surface of each subject was spatially normalized (see below) 
to allow thickness measurements of all patients or all controls to be combined before comparing the two groups 
with each other. (F) The mean thickness map of each retinal layer was compared between patients and controls 
using custom-designed software that performed parametric tests based on Gaussian RFT and non-parametric 
tests based on random permutations. These statistical techniques are well established in brain research and were 
adapted for the first time to the retina in the present study.
corrections of raw thickness values obtained in the A-scan direction. When the A-scan direction 
was not orthogonal to the layer due to retinal tilt and refraction effects, then raw measurement T’ of retinal layer 
thickness (distance between the layer’s delimiting surfaces in the A-scan direction) was greater than the true 
thickness value T.
As a result of retinal tilt with respect to the A-scan direction, raw thickness was not measured perpendicularly 
to the retinal layer, causing the measured thickness T’ to exceed the true value T. There are at least three types of 
tilt, depending on its origin. One type is global tilt (Fig. 6a), which is mainly due to pupil eccentricity at the entry 
of the OCT beam63. This tilt is constant over the scanned area and reached 10.0° in our subject 24, a value quite 
close to 11° reported by Antony et al.64. A second type of tilt is spherical tilt (Fig. 6b), which is due to natural cur-
vature of the eye. This curvature causes retinal tilt to increase radially, from zero near the center of the scanned 
area up to 7.0° at its corners, as in subject 10 in our study. The third type of tilt is local tilt (Fig. 6c), which is due to 
variation of the local orientation of each retinal layer. It varies at each point (x, y) of the scanned area and reached 
14.4° in the NFL very close to the fovea center in subject 23 in our study.
Global tilt was modelled for each subject using the vector normal to a plane fitted to points defining the outer 
surface of the RPE. Spherical tilt was modelled using the vector normal to the sphere surface (radius) resulting 
from the revolution of the circle fitted to the 512 points of the OB_RPE corresponding to the B-scan crossing the 
center of the scanned area. Local tilt at point (x, y) of a retinal layer was modelled using the normal vector of the 
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plane fitted to a 0.5 × 0.5 mm2 region of the medial surface of the layer in the flattened OCT, centered at (x, y). 
The flattened OCT was obtained through z-axis displacement of all A-scans so that z-coordinates of the outer 
delimiting surface of RPE became zero (or some other constant). The medial surface of a retinal layer was defined 
as the surface dividing the layer into two equally thick sub-layers. The z-coordinate at any scanned point (x, y) was 
obtained by averaging the z-coordinates of the same point on the two delimiting surfaces. The angle α between 
the A-scan direction (z-axis in OCT) and the vector sum of the three normal vectors was used to compute the true 
thickness T at each point in a retinal layer as T(x, y) = T’(x, y) cos α(x, y). Applying an additional correction for 
refraction effects was considered unnecessary because of the automatic segmentation algorithm.
Spatial normalization. Thickness maps in the x-y plane for each subject had to be first spatially normalized 
in order to allow thickness values from different subjects to be combined. This ensured that the values being aver-
aged together referred to the same anatomical region. Since OCT lacks standardized references analogous to brain 
maps in functional MRI, all OCT data were spatially normalized through translation, rotation and scaling. The 
thickness matrix of each subject was displaced in the x-y plane so that the fovea center cm came to the central point 
Figure 6. Tilt corrections. (a) Global tilt of OCT is modeled by the 3D unit vector U orthogonal to the plane 
fitted to the outer surface of the RPE. The angle γ between U and the direction of A-scans (A) represents the 
global tilt. (b) Curvature tilt, due to anatomical eye curvature, is modeled at each retinal point (x, y) by the unit 
vector V starting at that point and pointing to the center of the sphere S. This sphere is generated by revolution 
of the circle C fitted to points of the OB-RPE on the central B-can. Spherical tilt at any retinal point is given by 
the angle σ between V and A. (c) Local tilt of a retinal layer at a given retinal point is due to changes in local 
orientation of the layer across the scanned region and is modeled by the unit vector W orthogonal to the medial 
surface of the layer at that point. (d–f) Color coded values of global, spherical and local tilts (γ, σ and λ) for 
all scanned retinal points of GCL from subject 17. (g) Topographic representations of GCL thickness before 
correction, T’: 3D surface (top) and level contours (bottom). (h) Total tilt, obtained as the angle α between the 
A-scan direction and the vector sum of U + V + W. (i) Layer thickness T corrected for tilt and obtained as T(x, 
y) = T’(x, y) cos α(x, y). When corrected and uncorrected thickness maps in (g) and (i) are visually compared, 
the difference may be difficult to perceive from the upper surfaces, while representations of level contours on 
the floor of each figure clearly show slight changes in the shape of perifoveal regions as well as shrinking and 
splitting of the thickest region (red color), which demonstrates the thickness reduction resulting from the 
correction applied.
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of the image matrix (Fig. 7). The matrix was rotated so that the maculopapilar axis s of all subjects overlapped at 
an angle θ = 6.766°, and scaled so that all papillary centers cp overlapped at 4.377 mm from the common fovea 
center cm. These values of θ and s were the mean values in the entire study sample.
Statistical analysis. To investigate which areas of each retinal layer were altered in patients relative to con-
trols, matrices of raw thickness values with dimensions of 128 × 512 were resized to 512 × 512 using bilinear inter-
polation, then smoothed with an isotropic Gaussian filter whose variance was chosen based on theoretical and 
practical considerations. The theoretical consideration was that the filter’s full width at half maximum (FWHM) 
should be >4 times the voxel size in its lower-resolution dimension65, which in our case meant >187.5 µm. The 
practical consideration was that we wished to improve on the spatial resolution of previous studies, but without 
gaining a resolution so fine that might be spurious or inaccurate; retinal signals with a high spatial frequency 
may not be detected with sufficient signal-to-noise ratio with our OCT equipment. These considerations led us to 
choose FWHM = (1, 1) mm, giving a resel size of 1 × 1 mm2 and 36 resels for the entire scanned area.
The area searched for differences in retinal thickness between patients and controls was restricted to a cen-
tral circle of the scanned region, because data were not available outside that region for all subjects. This hap-
pens mainly because OCT rotation and scaling during spatial normalization generated empty peripheral regions 
and because the automatic layer segmentation failed in some peripheral regions of a small number of subjects, 
thus rendering layer thickness unavailable at those regions. The area searched for differences was therefore 
restricted to a fovea-centered square of 4.8 × 4.8 mm2. The search region for RFT-based analysis was restricted to 
a fovea-centered circle of diameter 3.5 mm. This region contained data from all subjects and covered the fovea and 
parafovea. Restricting the search region to this circle implied the resel count to be set at 17 resels66.
The family-wise null hypothesis can be tested in a variety of ways. We chose “height thresholding”, because 
voxels inside the search region with above-threshold signal allow us to conclude the existence of statistically sig-
nificant thinning in those voxels67. Other hypothesis-testing methods, in contrast, do not provide spatial localiza-
tion of effects. Family-wise error (FWE) probability under the null hypothesis was set to α = 0.05, and one-sided 
statistical tests were adopted. The total number of subjects was 43. The statistical parametric map for the macular 
region was built on the z statistic using a standard Gaussian distribution, and its critical value was computed for 
each layer according to RFT. For those layers whose data failed to satisfy the requirements of RFT, Bonferroni cor-
rection was discarded because nearby voxels could not be treated as mutually independent; we used instead the 
non-parametric permutation test68. This statistical testing was coded into in-house software to identify thinned 
regions in each retinal layer. Two versions of the software were independently developed and then cross-checked 
to ensure that results were reliable.
Spatial overlap of thinned/thickened regions of different layers was evaluated using Jaccard coefficients 
and hypothesis-tested using exact probability tests10,69. A Jaccard value was considered statistically significant 
when the probability of obtaining equal or more extreme values was below 0.05/(2 × 45) in a two-sided test with 
Bonferroni correction for the 45 layer pairs being compared. Given the extremely large integer numbers gener-
ated by combinatorial coefficients in probability computations, we used the Symbolic Math, Variable Precision 
Integer Arithmetic and High Precision Floating Point Arithmetic toolboxes in Matlab R2018a70. Determining the 
statistical significance of each Jaccard coefficient required in most cases approximately 19 h of computing time on 
a dedicated server with an Intel Xeon processor E5-2690 v3, 12 core, 2.6 GHz, 35 MB, and 32 GB RAM.
Figure 7. Parameters for spatial normalization: center of the fovea cm, center of the papilla cp, length s and angle 
θ of maculopapillar axis. All OCTs were moved, rotated and scaled so that their macular and papillar centers 
overlapped. Data on macula and papilla were acquired independently in two OCT sessions, so their coordinate 
systems could not be directly related to each other. Thus, the two datasets had to be co-registered based on 
shared retinal regions before maculopapilar axis length and angle could be computed.
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ethics approval and consent to participate. The study protocol followed the principles of the 
Declaration of Helsinki and was approved by the Ethics Committee for Clinical Research of the Hospital Clínico 
San Carlos (code number 11/372-E). All participants gave their written informed consent.
Data Availability
The datasets analysed during the current study are available in the Figshare repository, https://doi.org/10.6084/
m9.figshare.8323334.
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